TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells. (Q38929439)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Peter J Olbert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Marcus Henrici

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Florentine S Subtil

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Astrid Honacker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Axel Hegele

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Rainer Hofmann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jörg Hänze

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

10 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

110.e19-27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guérin by Flt3-ligand generated dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Recognition of microbial infection by Toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Toll-like receptors expressed in tumor cells: targets for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Toll-like receptors in normal and malignant human bladders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Tumour necrosis factor-alpha as a tumour promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.09.016

10.1016/J.UROLONC.2014.09.016

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25499923%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference